These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 23720244)
1. Interaction of CJY, an isoflavone, with ATPase of P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Cen J; Liu L; He L; Ji BS Drug Res (Stuttg); 2013 Aug; 63(8):429-34. PubMed ID: 23720244 [TBL] [Abstract][Full Text] [Related]
2. CJX1, an amlodipine derivative, interacts with ATPase of human P-glycoprotein. Ji BS; He L Cell Biol Int; 2009 Oct; 33(10):1073-8. PubMed ID: 19589390 [TBL] [Abstract][Full Text] [Related]
3. Interaction of CJZ3, a lomerizine derivative, with ATPase activity of human P-glycoprotein in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Ji BS; Li M; He L Pharmazie; 2010 Jul; 65(7):515-9. PubMed ID: 20662321 [TBL] [Abstract][Full Text] [Related]
4. Reversal of p-glycoprotein-mediated multidrug resistance by CJX1, an amlodipine derivative, in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Ji BS; He L; Liu GQ Life Sci; 2005 Sep; 77(18):2221-32. PubMed ID: 15967469 [TBL] [Abstract][Full Text] [Related]
5. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells. Ji BS; He L J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197 [TBL] [Abstract][Full Text] [Related]
6. CJY, an isoflavone, interacts with ATPase of P-glycoprotein in the rat brain microvessel endothelial cells (RBMECs). Li MS; Cen J; He L; Liu L; Ji BS J Chemother; 2013 Dec; 25(6):347-54. PubMed ID: 24090809 [TBL] [Abstract][Full Text] [Related]
7. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. He L; Liu GQ Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192 [TBL] [Abstract][Full Text] [Related]
8. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798 [TBL] [Abstract][Full Text] [Related]
9. Reversal of P-glycoprotein-mediated multidrug resistance by guggulsterone in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Xu HB; Li L; Liu GQ Pharmazie; 2009 Oct; 64(10):660-5. PubMed ID: 19947169 [TBL] [Abstract][Full Text] [Related]
10. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic. Ma B; Chai S; Li N; To KK; Kan WL; Yang D; Lin G Int J Pharm; 2012 Mar; 424(1-2):33-9. PubMed ID: 22226881 [TBL] [Abstract][Full Text] [Related]
11. [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells]. Peng YM; Wang N; Wang YF; Han L; Zhang Y; Jiang JH; Zhou YB; Wang QD Yao Xue Xue Bao; 2012 May; 47(5):594-9. PubMed ID: 22812001 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells. Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439 [TBL] [Abstract][Full Text] [Related]
13. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells. Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236 [TBL] [Abstract][Full Text] [Related]
14. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of P-glycoprotein expression by sustained intracellular acidification in K562/Dox cells. Lu Y; Pang T; Wang J; Xiong D; Ma L; Li B; Li Q; Wakabayashi S Biochem Biophys Res Commun; 2008 Dec; 377(2):441-446. PubMed ID: 18851949 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells. Munteanu E; Verdier M; Grandjean-Forestier F; Stenger C; Jayat-Vignoles C; Huet S; Robert J; Ratinaud MH Biochem Pharmacol; 2006 Apr; 71(8):1162-74. PubMed ID: 16499877 [TBL] [Abstract][Full Text] [Related]
17. The synergistic reversal effect of multidrug resistance by quercetin and hyperthermia in doxorubicin-resistant human myelogenous leukemia cells. Shen J; Zhang W; Wu J; Zhu Y Int J Hyperthermia; 2008 Mar; 24(2):151-9. PubMed ID: 18283591 [TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate. Wang C; Zhang JX; Shen XL; Wan CK; Tse AK; Fong WF Biochem Pharmacol; 2004 Sep; 68(5):843-55. PubMed ID: 15294447 [TBL] [Abstract][Full Text] [Related]
19. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells. Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047 [TBL] [Abstract][Full Text] [Related]
20. The novel anthracycline annamycin is not affected by P-glycoprotein-related multidrug resistance: comparison with idarubicin and doxorubicin in HL-60 leukemia cell lines. Consoli U; Priebe W; Ling YH; Mahadevia R; Griffin M; Zhao S; Perez-Soler R; Andreeff M Blood; 1996 Jul; 88(2):633-44. PubMed ID: 8695811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]